Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma-Reference-Cited by-同舟云学术

Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma

Published:2017-01-02 Issue:1 Volume:18 Page:51-62
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Feng Fei¹,Wang Bin¹,Sun Xiuxuan¹,Zhu Yumeng¹,Tang Hao²,Nan Gang¹,Wang Lijuan¹,Wu Bo¹,Huhe Muren¹,Liu Shuangshuang¹,Diao Tengyue¹,Hou Rong¹,Zhang Yang¹,Zhang Zheng¹

Affiliation:

1. National Translational Science Center for Molecular Medicine, Department of Cell Biology, Fourth Military Medical University, Xi'an, P.R. China

2. Pacific Meinuoke Biopharmaceutical Company, Changzhou, P.R. China

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1276126

Reference44 articles.

1. Cancer statistics, 2013

2. Non-small-cell lung cancer

3. CXC chemokine ligand 4 (CXCL4) is predictor of tumour angiogenic activity and prognostic biomarker in non-small cell lung cancer (NSCLC) patients undergoing surgical treatment

4. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide

5. Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity;MedComm;2024-03

2. CD147: an integral and potential molecule to abrogate hallmarks of cancer;Frontiers in Oncology;2023-11-07

3. Cell Culture Model Evolution and Its Impact on Improving Therapy Efficiency in Lung Cancer;Cancers;2023-10-15

4. Molecular and biological factors in the prognosis of head and neck squamous cell cancer;Molecular Biology Reports;2023-07-26

5. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway;Archives of Biochemistry and Biophysics;2023-07